“…15 In addition, a case of newly diagnosed UC was reported that required colectomy after mRNA-1273 vaccine. 16 In our case, the findings of chronicity (epithelitis, cryptitis, crypt abscess, architectural damage, basal plasmacytosis, and crypt atrophy) in the histopathology suggested that the patient had a predisposition to UC. We did not find any reported cases with newly diagnosed UC after BNT162b2 vaccination.…”
BNT162b2 is a messenger RNA vaccine for the prevention of the novel coronavirus disease 2019 caused by severe acute respiratory syndrome coronavirus 2 infection. The widespread use of this vaccination has brought along several adverse events. We present a patient with newly diagnosed ulcerative colitis after BNT162b2 vaccine.
“…Several case reports mentioned UC triggered by messenger RNA (mRNA) vaccines such as BNT162b2 and mRNA-1273, and Çağatay and colleagues believed that the BNT162b2 vaccine may have triggered a worsening of UC by activating nuclear factor-κB and interferon-alpha. [9][10][11] However, subsequent presentation of UC combined with arthropathy after receiving protein subunit vaccine as MVC-COVI1901 vaccine has not been previously reported. We speculate that the pathogenesis of this case could be correlated to the components of the MVC-COVI1901 vaccine (spike protein S-2P adjuvanted with CpG 1018 and aluminum hydroxide).…”
A 23‐year‐old man suffered from diarrhea after receiving the MVC‐COVI1901 vaccine. The patient then presented to our emergency department due to swelling and pain in his right knee. Synovial effusion studies of the right knee revealed inflammation. Gram and acid‐fast stains reported negative results and no crystals were found under a polarized light microscope. During his hospitalization, the patient underwent a colonoscopy and computed tomography (CT) due to bloody stool. Pancolitis was suspected under colonoscopy and an abdominal CT scan supported our diagnosis showing wall thickening and mucosal enhancement. Pathology showed distorted crypt architecture and acute cryptitis with abscesses. After excluding other causes of ulcerative colitis (UC), the patient was diagnosed with MVC‐COV1901 vaccine‐related UC and inflammatory bowel disease arthropathy. Subsequent presentation of UC and inflammatory bowel disease‐related arthropathy after receiving the MVC‐COVI1901 vaccine has not previously been reported. We speculate that the pathogenesis could be correlated to the vaccine's components (spike protein S‐2P adjuvanted with CpG 1018 and aluminum hydroxide) through the combination of 2 effects: the activation of Toll‐like receptor (TLR) 4 by S‐2P, and the activation of TLR9 and expression of interleukin‐13 by CpG‐1018 adjuvant. In conclusion, it is remarkable that the MVC‐COVI1901 vaccine may lead to the incidence of autoinflammatory diseases such as UC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.